Sponsor:
Australian & New Zealand Children's Haematology/Oncology Group
Code:
NCT06208657
Conditions
Childhood Cancer
Childhood Solid Tumor
Childhood Brain Tumor
Recurrent Cancer
Refractory Cancer
Eligibility Criteria
Sex: All
Age: 0 - 21
Healthy Volunteers: Not accepted
Interventions
Paxalisib, Irinotecan, Temozolomide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Australian & New Zealand Children's Haematology/Oncology Group on 2025-02-21.